Global Stable Isotope Labeled Compounds Market Size By Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15), By End-Use (Research Institutes, Pharmaceutical & Biopharmaceutical), By Geographic Scope And Forecast
안정동위원소 표지 화합물 시장 규모 및 예측
안정동위원소 표지 화합물 시장 규모는 2021년 2억 7,823만 달러로 평가되었고, 2023-2030년 연평균 3.64% 성장하여 2030년에는 3억 8,351만 달러에 달할 것으로 예상됩니다. 이 시장의 성장은 제약 및 생명공학 분야의 연구 활동 증가 등이 주요 요인으로 작용하고 있습니다. 또한 암 발병률이 증가하고 있는 것도 안정동위원소 표지 화합물을 이용한 연구 활동을 활발하게 하고 있습니다. 본 조사 보고서는 세계의 안정동위체 표지 화합물 시장을 종합적으로 평가했습니다. 주요 부문, 동향, 시장 성장 촉진요인, 경쟁 구도 시장에서 중요한 역할을 하고 있는 요인 등을 종합적으로 분석했습니다.
세계 안정동위원소 표지 화합물 시장의 정의
안정 동위원소 표지에는 다양한 화학 및 생화학 시스템의 모델링에 사용되는 추적자 역할을 하는 비방사성동위원소의 사용이 포함됩니다. 동위원소는 핵자기공명(NMR) 또는 질량분석(MS)을 통해 화합물을 식별할 수 있는 표지 역할을 합니다. 일반적으로 사용되는 안정 동위원소에는 2H, 13C, 15N이 있습니다. 안정동위원소 표지 화합물은 대사를 통한 독성 연구에 종사하는 연구자들 사이에서 큰 관심을 불러일으키고 있습니다. 그 역할은 방대한 대사 연구에서 in vivo 대사를 평가하는 데 있으며, 무시할 수 없을 정도로 커지고 있습니다. 대사체학 연구 외에도 안정동위원소 표지 화합물은 환경 분석, 단백질체학, 의료 진단 연구에 점점 더 많이 사용되고 있습니다.
세계의 안정동위체 표지 화합물 시장 개요
이 보고서 시장 전망 섹션은 주로 내재적 시장 역학, 시장 성장 촉진요인 및 과제, 시장 성장 억제요인, 기회를 다루고 있습니다. 시장 성장 촉진요인/억제요인은 내재적 요인이며, 시장 성장 촉진요인/과제는 외재적 요인입니다.
이 시장의 성장은 제약 및 생명공학 부문의 분석 활동 증가와 같은 요인에 의해 크게 좌우됩니다. 또한 암의 유병률이 증가하고 있는 것도 안정동위원소 표지 화합물을 이용한 분석 활동에 박차를 가하고 있습니다. 또한 안정동위원소 표지 화합물 시장은 맞춤형 의료 및 의약품 분야에서의 분석 활동이 활발해짐에 따라 일정 기간마다 증가하고 있으며, 이는 안정동위원소 표지 화합물 시장이 예측 기간 중 건전하게 성장할 수 있는 좋은 기회가 되고 있습니다. 그러나 안정동위원소 표지 화합물의 도입에는 고가의 설비 투자가 필요하며, 이는 플러그 성장의 가장 큰 장벽으로 작용하고 있습니다.
검증 분석에서는 1차 정보의 데이터 활용을 세분화하여 지식을 검증하고 본격적인 분석 연구의 집약에 활용하고 있습니다. 이 보고서는 소비자가 관심을 갖는 시장 부분에 대한 정량적, 정성적 추정을 포함하고 있습니다. '세계 안정동위원소 표지 화합물 시장'은 하위 부문으로 나뉘어져 있으며, 최신 동향에 대한 분류된 지식을 간격으로 제공할 수 있습니다.
목차
제1장 세계의 안정동위체 표지 화합물 시장 서론
제2장 개요
제3장 VERIFIED MARKET RESEARCH의 조사 방법
- 데이터 마이닝
- 밸리데이션
- 1차 자료
- 데이터 소스 리스트
제4장 세계의 안정동위체 표지 화합물 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
제5장 세계의 안정동위체 표지 화합물 시장 : 유형별
제6장 세계의 안정동위체 표지 화합물 시장 : 최종 용도별
제7장 세계의 안정동위체 표지 화합물 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 세계의 기타 지역
제8장 세계의 안정동위체 표지 화합물 시장 : 경쟁 구도
제9장 기업 개요
- Merck KGaA
- Cambridge Isotope Laboratories, Inc.
- PerkinElmer Inc.
- Medical Isotopes, Inc.
- Omicron Biochemicals, Inc.
- Taiyo Nippon Sanso Corporation
- Isosciences
- Trace Sciences International
- Alsachim
- Urenco Stable Isotopes
제10장 주요 발전
- 제품 출시/개발
- 합병과 인수
- 사업 확대
- 파트너십과 제휴
제11장 부록
KSA
Stable Isotope Labeled Compounds Market Size And Forecast
Stable Isotope Labeled Compounds Market size was valued at USD 278.23 Million in 2021 and is projected to reach USD 383.51 Million by 2030 , growing at a CAGR of 3.64% from 2023 to 2030. The growth of this market is majorly driven by factors such as the increase in research activities in the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled research activities using such stable isotope-labeled compounds. The Global Stable Isotope Labeled Compounds Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Stable Isotope Labeled Compounds Market Definition
Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers used to model different chemical and biochemical systems. The isotope can act as an identifiable label on that compound through nuclear magnetic resonance (NMR) and mass spectrometry (MS). The Commonly used stable isotopes include 2H, 13C, and 15N. Stable isotope-labeled compounds have generated considerable interest among researchers engaged in metabolism-mediated toxicity studies. Their role has risen to insignificance in the assessment of in vivo metabolism in a vast range of metabolic research. Apart from metabolomics studies, stable isotope-labeled compounds are being increasingly used in environmental analysis, proteomics, and medical diagnostic research.
Global Stable Isotope Labeled Compounds Market Overview
The report's market outlook section primarily encompasses essential market dynamics, drivers, restraints, opportunities, and challenges the trade faces. Drivers and restraints are intrinsic factors, whereas opportunities and challenges are extrinsic factors of the market.
The growth of this market is majorly driven by factors like the rise in analysis activities within the pharmaceutical and biotechnology sector. Also, the rising prevalence of cancer has fuelled analysis activities using such stable isotope-labeled compounds. Moreover, the increase at intervals in the Stable Isotope Labeled Compounds Market due to the rise in analysis activity, significantly at intervals in the area of customized medicine and medicines, presents a superb chance for the Stable Isotope Labeled Compounds Market to grow healthy over the forecast amount. However, implementing stable isotope-labeled compounds needs high capital investments, which is the most critical barrier to plug growth.
Verified analysis narrows down their data exploitation of primary sources to validate the knowledge and use it in the aggregation of a full-fledged analysis study. The report contains a quantitative and qualitative estimation of market parts that interest the consumer. The "Global Stable Isotope Labeled Compounds Market" is split into sub-segments that can provide classified knowledge regarding the most recent trends at intervals.
Global Stable Isotope Labeled Compounds Market: Segmentation Analysis
The Global Stable Isotope Labeled Compounds Market is Segmented on the basis of Type, End-Use, and Geography.
Stable Isotope Labeled Compounds Market, By Type
- Deuterium
- Oxygen-18
- Carbon-13
- Nitrogen-15
Based on Type, the market is segmented into Deuterium, Oxygen-18, Carbon-13, and Nitrogen-15. Deuterium accounted for the largest market share in 2019 followed by Oxygen-18. Deuterium-labeled compounds have been utilized efficiently by toxicologists and drug metabolism scientists to gain an understanding of drug disposition and the potential performance of these compounds in the target organ toxicities.
Stable Isotope Labeled Compounds Market, By End-Use
- Research Institutes
- Pharmaceutical & Biopharmaceutical
- Others
Based on End-Use, the market is segmented into Research Institutes, Pharmaceutical & Biopharmaceutical, and Others. Research Institutes accounted for the largest market share in 2019. Government research institutes, medical research institutes, and academic research institutes employ stable isotope-labeled compounds for performing metabolomics and proteomics research studies.
Stable Isotope Labeled Compounds Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
- On the basis of Regional Analysis, the Global Stable Isotope Labeled Compounds Market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the major contributor to the Stable Isotope Labeled Compounds Market partly due to the prevalence of cancer treatment and its research as well as the rising older population in the Americas.
Key Players
- The "Global Stable Isotope Labeled Compounds Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
- Merck KGaA, Cambridge Isotope Laboratories, Inc., PerkinElmer Inc., Medical Isotopes, Inc., Omicron Biochemicals, Inc., Taiyo Nippon Sanso Corporation, Isosciences, Trace Sciences International, Alsachim, Urenco Stable Isotopes.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with their product benchmark and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
- In July 2021, Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, has launched the first commercially available 12C-enriched methane-grade gas for quantum applications.
- In July 2021, Bruker has entered into a partnership with Massachusetts-based Cambridge Isotope Laboratories (CIL), formalizing a long-term relationship between the two companies and further extending Bruker's capabilities to deliver end-to-end service solutions to its installed customer base in nuclear magnetic resonance (NMR) spectroscopy under the LabScape(R) brand.
- In June 2020, Creative Proteomics, the main provider in proteomics and metabolomics services, delivered a few proteomics services to scientists. The assistance ranges incorporate four: iTRAQ naming help, name-free quantitation service, SILAC mass spectrometry service, and TMT proteomics service.
- In June 2020, Cambridge Isotope Laboratories, (CIL) the largest manufacture and global supplier of stable isotopes and stable isotope-labeled compounds, collaborated with Alsachim to provide antiviral drug standards to researchers and clinicians exclusively in the Americas. These products are available through CIL in convenient packaging sizes and are adept for use as internal standards in therapeutic monitoring and quantitative analysis.
- In December 2020, Cambridge Isotope Laboratories, Inc. (CIL), the world leader in stable isotope chemistry and the separation of carbon-13 (13C), recently began a significant capacity optimization of one of the production cascades at the 13C separation facility in Xenia, Ohio. This optimization, which began this past summer and is scheduled for completion in the summer of 2021, will increase the cascade's 13C production by 10%.
- Merger & Acquisitions
- In April 2018, TAIYO NIPPON SANSO CORPORATION totally acquired SAIL advances Inc., where it's valuable in assembling and conveying stable isotope-marked amino acids that are material in biotechnology-related businesses and the medication industry.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
5 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY TYPE
- 5.1 Overview
- 5.2 Carbon-13
- 5.3 Nitrogen-15
- 5.4 Deuterium
- 5.5 Oxygen-18
6 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY END-USE
- 6.1 Overview
- 6.2 Research Institutes
- 6.3 Pharmaceutical & Biopharmaceutical
- 6.4 Others
7 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET, BY GEOGRAPHY
- 7.1 Overview
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
- 7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East & Africa
8 GLOBAL STABLE ISOTOPE LABELED COMPOUNDS MARKET COMPETITIVE LANDSCAPE
- 8.1 Overview
- 8.2 Company Market Ranking
- 8.3 Key Development Strategies
9 COMPANY PROFILES
- 9.1 Merck KGaA
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 Cambridge Isotope Laboratories, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 PerkinElmer Inc.
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 Medical Isotopes, Inc.
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 Omicron Biochemicals, Inc.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Taiyo Nippon Sanso Corporation
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Isosciences
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 9.8 Trace Sciences International
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
- 9.9 Alsachim
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
- 9.10 Urenco Stable Isotopes
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
10 KEY DEVELOPMENTS
- 10.1 Product Launches/Developments
- 10.2 Mergers and Acquisitions
- 10.3 Business Expansions
- 10.4 Partnerships and Collaborations
11 Appendix
